163 related articles for article (PubMed ID: 38742973)
1. The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
Mendiratta-Lala M; Fetzer D; Kamaya A; Parikh ND; Singal AG
Radiology; 2024 May; 311(2):e232624. PubMed ID: 38742973
[TBL] [Abstract][Full Text] [Related]
2. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
3. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
4. Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance.
An JY; Peña MA; Cunha GM; Booker MT; Taouli B; Yokoo T; Sirlin CB; Fowler KJ
Radiographics; 2020; 40(7):1916-1931. PubMed ID: 33136476
[TBL] [Abstract][Full Text] [Related]
5. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score.
Truong TN; Pham TND; Hoang LB; Nguyen VT; Dao HV; Dao DVB; Alessy S; Pham HB; Pham TTT; Nguyen LDD; Nguyen K; Abaalkhail F; Manal M; Mawardi M; AlZahrani M; Alswat K; Alghamdi H; Sanai FM; Siddiqui MA; Nguyen NH; Vaidya D; Phan HT; Johnson PJ; Alqahtani SA; Dao DY
BMC Cancer; 2023 Sep; 23(1):875. PubMed ID: 37723439
[TBL] [Abstract][Full Text] [Related]
8. Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study.
van de Braak C; Willemssen FEJA; de Man RA; van der Lugt A; Uyl-de Groot CA; Bos D; Dwarkasing RS
Eur Radiol Exp; 2024 Mar; 8(1):29. PubMed ID: 38467990
[TBL] [Abstract][Full Text] [Related]
9. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
10. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
Yokoo T; Masaki N; Parikh ND; Lane BF; Feng Z; Mendiratta-Lala M; Lee CH; Khatri G; Marsh TL; Shetty K; Dunn CT; Al-Jarrah T; Aslam A; Davenport MS; Gopal P; Rich NE; Lok AS; Singal AG
Radiology; 2023 Apr; 307(2):e220917. PubMed ID: 36692401
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.
Brunsing RL; Chen DH; Schlein A; Wolfson T; Gamst A; Mamidipalli A; Vietti Violi N; Marks RM; Taouli B; Loomba R; Kono Y; Sirlin CB
Radiol Imaging Cancer; 2019 Nov; 1(2):e190010. PubMed ID: 33778680
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach.
Koo E; Singal AG
Surg Oncol Clin N Am; 2024 Jan; 33(1):13-28. PubMed ID: 37945138
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
[TBL] [Abstract][Full Text] [Related]
15. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Parikh ND; Tayob N; Singal AG
J Hepatol; 2023 Jan; 78(1):207-216. PubMed ID: 36089157
[TBL] [Abstract][Full Text] [Related]
16. Emerging Tools for Hepatocellular Carcinoma Surveillance.
Singal AG; Reig M; Villanueva A
Am J Gastroenterol; 2022 Dec; 117(12):1948-1951. PubMed ID: 36114768
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
[TBL] [Abstract][Full Text] [Related]
19. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
[TBL] [Abstract][Full Text] [Related]
20. Early detection of hepatocellular carcinoma: roadmap for improvement.
Melendez-Torres J; Singal AG
Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
